endomorphin-1 has been researched along with alpha-chymotrypsin* in 1 studies
1 other study(ies) available for endomorphin-1 and alpha-chymotrypsin
Article | Year |
---|---|
Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance.
In this paper we describe the synthesis and affinity toward the mu-opioid receptor of some tetrapeptides obtained from endomorphin-1, H-Tyr-Pro-Trp-Phe-NH(2) (1), by substituting each amino acid in turn with its homologue. The ability to bind mu-opioid receptors depends on the beta-amino acid, and in particular 4, which contains beta-L-Pro, has a K(I) in the nanomolar range. The peptides 4 and 5 are significantly more resistant to enzymatic hydrolysis than 1. The same compounds, as well as the mu-opioid receptor agonist DAMGO, produced a concentration-dependent inhibition of forskolin-stimulated cyclic AMP formation, thus behaving as mu-opioid agonists. These features suggest that this novel class of endomorphin-1 analogues may represent suitable candidates for the in vivo investigation as potential mu-opioid receptor agonists. Topics: Animals; Binding, Competitive; Brain; Carboxypeptidases; Cathepsin A; CD13 Antigens; Chymotrypsin; Cyclic AMP; Hydrolysis; In Vitro Techniques; Oligopeptides; Proline; Radioligand Assay; Rats; Receptors, Opioid, mu; Stereoisomerism; Tumor Cells, Cultured | 2002 |